SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,756.43+0.38%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Lineage Cell Therapeutics Inc (LCTX) Stock Price, Quote, News & History

LCTXAMEX
Trade with Public
Trade with Public
$1.03
0.08228.67%
At close: Sep 25, 5:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Lineage Cell Therapeutics (LCTX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$0.95
Close
$1.03
Volume / Avg.
2.48M / 1.39M
Day Range
$0.94 - $1.04
52 Wk Range
0.91 - 2.09
Market Cap
$239.71M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
47
Short Interest
19.33%
Days to Cover
26.64

Recent Lineage Cell Therapeutics Inc News

Service Properties Trust, ConocoPhillips And Other Big Stocks Moving Lower In Monday's Pre-Market Session

US stock futures up, Nasdaq 100 gains 100 pts. Service Properties Trust (SVC) drops 4% in pre-market trading. Other decliners: MGRT, UP, CDZI, LCTX, KEP, AUTL, EOG, ANGX, COP.
Avi Kapoor

Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Two Biotech Stocks Poised For Big Moves On Monday

David Pinsen

Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Avi Kapoor

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-23.82M
Investing Cash Flow (TTM)
-13.71M
Financing Cash Flow (TTM)
32.24M
Free Cash Flow (TTM)
-24.39M
Capital Expenditure (TTM)
-574.00K
Net Change in Cash (TTM)
-5.29M

Analyst Trends and Forecast

1
Apr
1
May
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$211.96M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
17.91
PB Ratio (TTM)
3.94
Earnings Yield % (TTM)
-20.05%
Earnings Yield % (FWD)
-13.72%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.24

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$54.00K
Total Cash
$37.35M
Debt to Equity
0.04
Issuance of Debt (TTM)
-$54.00K
Repayment of Debt (TTM)
-$54.00K

Key Statistics

Open
$0.95
Close
$1.03
Volume / Avg.
2.48M / 1.39M
Day Range
$0.94 - $1.04
52 Wk Range
0.91 - 2.09
Market Cap
$239.71M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
47
Short Interest
19.33%
Days to Cover
26.64

About

Sector
Health Care
Industry
Biotechnology
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonanc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Lineage Cell Therapeutics (LCTX) stock?

A

You can purchase shares of Lineage Cell Therapeutics (AMEX:LCTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lineage Cell Therapeutics (LCTX) competitors?

Q

What is the forecast, or price target, for Lineage Cell Therapeutics (LCTX) stock?

A

Lineage Cell Therapeutics has a consensus price target of $5.43.

Q

What is the current price for Lineage Cell Therapeutics (LCTX)?

A

The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $ last updated .

Q

Does Lineage Cell Therapeutics (LCTX) pay a dividend?

A

There are no upcoming dividends for Lineage Cell Therapeutics.

Q

When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?

A

Lineage Cell Therapeutics does not have any upcoming earnings scheduled.

Q

Is Lineage Cell Therapeutics (LCTX) going to split?

A

There is no upcoming split for Lineage Cell Therapeutics.

Q

What sector and industry does Lineage Cell Therapeutics (LCTX) operate in?

A

Lineage Cell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved